Minerva Neurosciences, Inc.
NERV
$2.39
-$0.045-1.85%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 15.25M | 17.29M | 21.36M | 26.53M | 30.88M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 199.60K | 534.80K | 806.90K | 1.31M | 428.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 100.00K | 100.00K | 100.00K | 100.00K | 100.00K |
Total Current Assets | 15.55M | 17.92M | 22.27M | 27.94M | 31.41M |
|
|||||
Total Current Assets | 15.55M | 17.92M | 22.27M | 27.94M | 31.41M |
Net Property, Plant & Equipment | 2.70K | 4.10K | 5.40K | 6.80K | 8.20K |
Long-term Investments | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M |
Goodwill | 14.87M | 14.87M | 14.87M | 14.87M | 14.87M |
Total Other Intangibles | -- | -- | -- | -- | 4.30K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 30.42M | 32.80M | 37.14M | 42.81M | 46.29M |
|
|||||
Total Accounts Payable | 896.80K | 639.90K | 1.61M | 553.20K | 828.30K |
Total Accrued Expenses | 1.63M | 1.31M | 1.23M | 3.93M | 3.38M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 2.53M | 1.95M | 2.84M | 4.48M | 4.20M |
|
|||||
Total Current Liabilities | 2.53M | 1.95M | 2.84M | 4.48M | 4.20M |
Long-Term Debt | 60.00M | 60.00M | 60.00M | 60.00M | 86.58M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 62.53M | 61.95M | 62.84M | 64.48M | 90.78M |
|
|||||
Common Stock & APIC | 370.28M | 369.98M | 369.68M | 369.43M | 369.13M |
Retained Earnings | -402.39M | -399.13M | -395.38M | -391.10M | -413.62M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -32.11M | -29.15M | -25.69M | -21.67M | -44.49M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -32.11M | -29.15M | -25.69M | -21.67M | -44.49M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -32.11M | -29.15M | -25.69M | -21.67M | -44.49M |
|